Cancer epigenomics

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Epigenetics is the study of informationmaintained duringmitotic division other than the DNA sequence itself and includes DNA methylation, and modifi- cation of chromatin histone tails. Both DNA methylation and chromatin structure are essential to normal growth and development in mammals and regulate diverse functions such as imprinting, genomic stability, and gene transcription. Incorrect establishment, maintenance, or recognition of epigenetic marks can lead to a wide range of human diseases including immunodeficiency, centromeric region instability and facial anomalies syndrome (ICF), Rett syndrome, and cancer. In human cancer, both global hypomethylation of DNA across the genome and locus specific hypermethylation of DNA in promoters are common, thus are hallmarks of malignancy. Changes in transcription of histone tail modifying enzymes have also been well documented in a variety of human tumors. Although a great deal is known about epigenetic changes in cancer at the single gene level, little is known about the cancer epigenome; a genome-wide approach is likely to reveal important new insights that can not been seen from the single gene viewpoint. In this chapter we will describe new technologies used to study the epigenome and review what we have learned about the cancer epigenome using these new approaches.

Original languageEnglish (US)
Title of host publicationEpigenomics
PublisherSpringer Netherlands
Pages385-395
Number of pages11
ISBN (Print)9781402091872, 9781402091865
DOIs
StatePublished - 2009

Fingerprint

Epigenomics
Neoplasms
DNA Methylation
Histones
Chromatin
Tail
Genome
Genes
Rett Syndrome
Genomic Instability
DNA
Growth and Development
Cations
Mammals
Maintenance
Technology
Enzymes

Keywords

  • Cancer
  • Chromatin Modification
  • DNA methylation
  • Epigenomic

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Cancer epigenomics. / Ladd-Acosta, Christine Marie; Feinberg, Andrew P.

Epigenomics. Springer Netherlands, 2009. p. 385-395.

Research output: Chapter in Book/Report/Conference proceedingChapter

Ladd-Acosta, Christine Marie ; Feinberg, Andrew P. / Cancer epigenomics. Epigenomics. Springer Netherlands, 2009. pp. 385-395
@inbook{ecd177bc81da434082e0630580e82bf5,
title = "Cancer epigenomics",
abstract = "Epigenetics is the study of informationmaintained duringmitotic division other than the DNA sequence itself and includes DNA methylation, and modifi- cation of chromatin histone tails. Both DNA methylation and chromatin structure are essential to normal growth and development in mammals and regulate diverse functions such as imprinting, genomic stability, and gene transcription. Incorrect establishment, maintenance, or recognition of epigenetic marks can lead to a wide range of human diseases including immunodeficiency, centromeric region instability and facial anomalies syndrome (ICF), Rett syndrome, and cancer. In human cancer, both global hypomethylation of DNA across the genome and locus specific hypermethylation of DNA in promoters are common, thus are hallmarks of malignancy. Changes in transcription of histone tail modifying enzymes have also been well documented in a variety of human tumors. Although a great deal is known about epigenetic changes in cancer at the single gene level, little is known about the cancer epigenome; a genome-wide approach is likely to reveal important new insights that can not been seen from the single gene viewpoint. In this chapter we will describe new technologies used to study the epigenome and review what we have learned about the cancer epigenome using these new approaches.",
keywords = "Cancer, Chromatin Modification, DNA methylation, Epigenomic",
author = "Ladd-Acosta, {Christine Marie} and Feinberg, {Andrew P}",
year = "2009",
doi = "10.1007/978-1-4020-9187-2_21",
language = "English (US)",
isbn = "9781402091872",
pages = "385--395",
booktitle = "Epigenomics",
publisher = "Springer Netherlands",

}

TY - CHAP

T1 - Cancer epigenomics

AU - Ladd-Acosta, Christine Marie

AU - Feinberg, Andrew P

PY - 2009

Y1 - 2009

N2 - Epigenetics is the study of informationmaintained duringmitotic division other than the DNA sequence itself and includes DNA methylation, and modifi- cation of chromatin histone tails. Both DNA methylation and chromatin structure are essential to normal growth and development in mammals and regulate diverse functions such as imprinting, genomic stability, and gene transcription. Incorrect establishment, maintenance, or recognition of epigenetic marks can lead to a wide range of human diseases including immunodeficiency, centromeric region instability and facial anomalies syndrome (ICF), Rett syndrome, and cancer. In human cancer, both global hypomethylation of DNA across the genome and locus specific hypermethylation of DNA in promoters are common, thus are hallmarks of malignancy. Changes in transcription of histone tail modifying enzymes have also been well documented in a variety of human tumors. Although a great deal is known about epigenetic changes in cancer at the single gene level, little is known about the cancer epigenome; a genome-wide approach is likely to reveal important new insights that can not been seen from the single gene viewpoint. In this chapter we will describe new technologies used to study the epigenome and review what we have learned about the cancer epigenome using these new approaches.

AB - Epigenetics is the study of informationmaintained duringmitotic division other than the DNA sequence itself and includes DNA methylation, and modifi- cation of chromatin histone tails. Both DNA methylation and chromatin structure are essential to normal growth and development in mammals and regulate diverse functions such as imprinting, genomic stability, and gene transcription. Incorrect establishment, maintenance, or recognition of epigenetic marks can lead to a wide range of human diseases including immunodeficiency, centromeric region instability and facial anomalies syndrome (ICF), Rett syndrome, and cancer. In human cancer, both global hypomethylation of DNA across the genome and locus specific hypermethylation of DNA in promoters are common, thus are hallmarks of malignancy. Changes in transcription of histone tail modifying enzymes have also been well documented in a variety of human tumors. Although a great deal is known about epigenetic changes in cancer at the single gene level, little is known about the cancer epigenome; a genome-wide approach is likely to reveal important new insights that can not been seen from the single gene viewpoint. In this chapter we will describe new technologies used to study the epigenome and review what we have learned about the cancer epigenome using these new approaches.

KW - Cancer

KW - Chromatin Modification

KW - DNA methylation

KW - Epigenomic

UR - http://www.scopus.com/inward/record.url?scp=84920020547&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920020547&partnerID=8YFLogxK

U2 - 10.1007/978-1-4020-9187-2_21

DO - 10.1007/978-1-4020-9187-2_21

M3 - Chapter

AN - SCOPUS:84920020547

SN - 9781402091872

SN - 9781402091865

SP - 385

EP - 395

BT - Epigenomics

PB - Springer Netherlands

ER -